Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) — The “Quantum Computing in Drug Discovery Market Report and Forecast 2024-2032” report has been added to ResearchAndMarkets.com’s offering.
The global quantum computing in drug discovery market was valued at USD 400 million in 2023. The market is expected to grow at a CAGR of 13% during the period 2024-2032, reaching USD 1.20 billion by 2032
This growth is driven by the increasing adoption of artificial intelligence in the healthcare domain, advancements in quantum computing technology, rising investment from pharmaceutical companies, and supportive government policies and investments in healthcare research infrastructure.
Quantum computing in drug discovery leverages quantum mechanics to solve complex molecular and chemical interactions, significantly accelerating the process of identifying and developing new drugs. This technology promises to transform drug discovery by enhancing the accuracy and efficiency of simulations and predictions, potentially reducing the time and cost involved in bringing new drugs to market. The market for quantum computing in drug discovery is growing due to advancements in quantum technology and increasing investments from pharmaceutical and technology companies.
Market Driver
Advancements in Quantum Computing Technology: Continuous innovations in quantum computing technology are a major driver for its application in drug discovery. These advancements enhance the ability to model complex biological systems and chemical reactions with unprecedented precision, speeding up the discovery process and improving the accuracy of drug development.
Increasing Investment from Pharmaceutical Companies: Pharmaceutical companies are increasingly investing in quantum computing to gain a competitive edge in drug discovery. The ability to rapidly identify and validate drug targets, generate leads, and optimize compounds can significantly reduce the time and cost of drug development, driving market growth.
Rising Demand for Efficient Drug Discovery Processes: The growing need for more efficient and cost-effective drug discovery processes is propelling the adoption of quantum computing. This technology enables detailed simulations and accurate predictions, which can streamline various stages of drug development, from target identification to lead optimization.
Market Challenges
High Cost of Quantum Computing Systems: The high cost associated with quantum computing systems can be a significant barrier to widespread adoption. The expense of acquiring and maintaining advanced quantum hardware and software may limit accessibility, particularly for smaller pharmaceutical companies and research institutions.
Technical Complexity and Skill Requirements: Quantum computing technology is highly complex and requires specialized knowledge and skills. The scarcity of professionals trained in quantum computing and its applications in drug discovery can hinder the market’s growth. Efforts to provide education and training in this field are essential.
Regulatory and Ethical Issues: The integration of quantum computing in drug discovery must navigate regulatory and ethical challenges. Ensuring compliance with existing regulations and addressing concerns related to data security and patient safety are crucial for the successful implementation of this technology.
Future Opportunities
Collaborations and Partnerships: Strategic collaborations and partnerships between quantum computing companies and pharmaceutical firms can drive innovation and market growth. Joint efforts can lead to the development of new quantum algorithms and solutions tailored to drug discovery, enhancing the capabilities of both industries.
Expansion into Emerging Markets: Expanding quantum computing applications into emerging markets presents substantial growth opportunities. As healthcare infrastructure and research capabilities improve in these regions, there is significant potential for adopting advanced technologies like quantum computing in drug discovery.
Development of Quantum Software Solutions: The development of specialized quantum software solutions for drug discovery offers significant market potential. Tailored software can enhance the efficiency and accuracy of quantum simulations and predictions, making the technology more accessible and effective for pharmaceutical research.
Global Quantum Computing in Drug Discovery Market Trends
Integration with Artificial Intelligence and Machine Learning: The integration of quantum computing with artificial intelligence (AI) and machine learning (ML) is a growing trend. AI and ML can enhance the capabilities of quantum algorithms, providing more accurate predictions and insights for drug discovery. This combination can significantly accelerate the drug development process.
Increasing Use of Quantum Simulations: The use of quantum simulations to model complex molecular structures and chemical reactions is becoming more prevalent. These simulations provide detailed insights that are not possible with classical computing, improving the accuracy of drug discovery and development processes.
Focus on Personalized Medicine: The trend toward personalized medicine is driving the adoption of quantum computing in drug discovery. Quantum computing can help develop tailored treatments by analyzing individual genetic and molecular profiles, leading to more effective and targeted therapies.
Growth in Quantum Computing Research: There is a significant increase in research focused on quantum computing applications in drug discovery. Academic institutions and research organizations are investing in exploring new quantum algorithms and techniques to solve complex biological problems, driving innovation and market growth.
Global Quantum Computing in Drug Discovery Market Competitive Landscape
The global quantum computing in drug discovery market features key players such as IBM Corp., Alphabet Inc., D-Wave Systems Inc., Microsoft Corporation, Rigetti Computing Inc., Quantum Brilliance Pty Ltd, Xanadu Quantum Technologies Inc., Fujitsu Limited, Intel Corporation, Atos SE, and 1QB Information Technologies, Inc.
These companies drive market growth through innovations in quantum computing, strategic partnerships, and market expansion efforts. They offer advanced quantum hardware and software solutions tailored for drug discovery, enhancing the efficiency and accuracy of research processes. Continuous research and development, coupled with collaborations between quantum computing and pharmaceutical companies, strengthen their market presence and drive innovation in the field.
Supplier Landscape
- IBM Corp.
- Alphabet Inc
- D-Wave Systems Inc.
- Microsoft Corporation
- Rigetti Computing Inc.
- Quantum Brilliance Pty Ltd
- Xanadu Quantum Technologies Inc.
- Fujitsu Limited
- Intel Corporation
- Atos SE
- 1QB Information Technologies, Inc.
Patent Analysis
- Analysis by Type of Patent
- Analysis by Publication Year
- Analysis by Issuing Authority
- Analysis by Patent Age
- Analysis by CPC Analysis
- Analysis by Patent Valuation
- Analysis by Key Players
Grant Analysis
- Analysis by Year
- Analysis by Amount Awarded
- Analysis by Issuing Authority
- Analysis by Grant Product
- Analysis by Funding Institute
- Analysis by Departments
- Analysis by Recipient Organization
Funding and Investment Analysis
- Analysis by Funding Instances
- Analysis by Type of Funding
- Analysis by Funding Amount
- Analysis by Leading Players
- Analysis by Leading Investors
- Analysis by Geography
Strategic Initiatives
- Analysis by Partnership Instances
- Analysis by Type of Partnership
- Analysis by Leading Players
- Analysis by Geography
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 200 |
| Forecast Period | 2024 – 2032 |
| Estimated Market Value (USD) in 2024 | $451.4 Million |
| Forecasted Market Value (USD) by 2032 | $1200 Million |
| Compound Annual Growth Rate | 13.0% |
| Regions Covered | Global |
Key Topics Covered:
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Quantum Computing in Drug Discovery Market Overview
3.1 Global Quantum Computing in Drug Discovery Market Historical Value (2017-2023)
3.2 Global Quantum Computing in Drug Discovery Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Quantum Computing in Drug Discovery Market Landscape*
5.1 Global Quantum Computing in Drug Discovery Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Quantum Computing in Drug Discovery Market: Product Landscape
5.2.1 Analysis by Offering
5.2.2 Analysis by Therapeutic Area
6 Global Quantum Computing in Drug Discovery Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Quantum Computing in Drug Discovery Market Segmentation (2017-2032)
7.1 Global Quantum Computing in Drug Discovery Market (2017-2032) by Offering
7.1.1 Market Overview
7.1.2 Target Identification/ Validation
7.1.3 Hit Generation / Lead Identification
7.1.4 Lead Optimization
7.1.5 Others
7.2 Global Quantum Computing in Drug Discovery Market (2017-2032) by Therapeutic Area
7.2.1 Market Overview
7.2.2 Cardiovascular Disorders
7.2.3 CNS Disorders
7.2.4 Dermatological Disorders
7.2.5 Endocrine Disorders
7.2.6 Gastrointestinal Disorders
7.2.7 Immunological Disorders
7.2.8 Infectious Diseases
7.2.9 Musculoskeletal Disorders
7.2.10 Oncological Disorders
7.2.11 Respiratory Disorders
7.2.12 Others
7.3 Global Quantum Computing in Drug Discovery Market (2017-2032) by End User
7.3.1 Market Overview
7.3.2 Pharmaceutical Companies
7.3.3 Biopharmaceutical Companies
7.3.4 Research and Academic Institute
7.3.5 Others
7.4 Global Quantum Computing in Drug Discovery Market (2017-2032) by Region
For more information about this report visit https://www.researchandmarkets.com/r/pyrhy7
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Quantum Computing in Drug Discovery Market
